2 Bambusa Therapeutics insiders buy within 14 days
Two Bambusa Therapeutics
- $12,000,000[1]
Two Bambusa Therapeutics (BBTX) insiders bought stock within 14 days, Form 4 filings show: 2 purchases totaling $12,000,000 on Nov 2. The largest was Helmut Wolfgang Jeggle, director, at $6,000,000.[1]
| Insider | Role | Trade date | Shares | Value | Reporting delay |
|---|---|---|---|---|---|
| Helmut Wolfgang Jeggle | director | 2026-11-02 | 375,000 | $6,000,000 | the same day |
| Salvia Investment GmbH | 10% owner | 2026-11-02 | 375,000 | $6,000,000 | the same day |
Who bought and when?
All 2 purchases were made on Nov 2. Helmut Wolfgang Jeggle made the largest purchase, $6,000,000.[1]
How unusual is the group?
0 further insiders filed a purchase at BBTX in the 14 days before the earliest trade in this group.[2]
What do these filings not show?
Each Form 4 reports one insider. Together they do not show why anyone bought or whether the group acted together.[1]
BBTX insider trading activity
In open-market trades dated in the last 90 days, 2 insiders bought $12M and no insider sold, per Form 4 filings.
- Helmut Wolfgang Jeggle (Director) bought 375,000 shares for $6M, last filed Nov 2.
- Salvia Investment GmbH (10% owner) bought 375,000 shares for $6M, last filed Nov 2.
Get BBTX alerts
Set a BBTX price alert, or get one when a fund, insider or politician you follow trades.
